US-backed hepatitis B vaccine trial in Guinea-Bissau halted
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
A hepatitis B vaccine trial involving newborns in Guinea-Bissau will not proceed after failing to secure government approval. The study was set to receive $1.6m from the CDC and $1.6m from private partners; the government now controls the researchers’ vaccines and plans a universal birth dose in 2028.
Continue in the app — vote & join in ➔Source: Guardian Wellness · via ahirlevel.hu